Notice2026-04323
Glycine From the People's Republic of China: Notice of Final Results of Antidumping Duty Changed Circumstances Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 4, 2026
Issuing agencies
Commerce DepartmentInternational Trade Administration
Abstract
The U.S. Department of Commerce (Commerce) determines, in the context of this changed circumstances review (CCR) of the antidumping duty (AD) order on glycine from the People's Republic of China (China), that Salvi Chemical Industries Ltd. (Salvi) is ineligible to participate in the importer certification process because Salvi failed to demonstrate that it no longer uses Chinese-origin glycine in its production process and failed to demonstrate that it maintains its books and records to accurately document the origin of the in-scope materials entering its inventory which are used to process glycine. As a result, glycine produced, processed, or exported by Salvi continues to be subject to the AD order on glycine from China.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 42 (Wednesday, March 4, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 42 (Wednesday, March 4, 2026)]
[Notices]
[Pages 10588-10589]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-04323]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
International Trade Administration
[A-570-836]
Glycine From the People's Republic of China: Notice of Final
Results of Antidumping Duty Changed Circumstances Review
AGENCY: Enforcement and Compliance, International Trade Administration,
Department of Commerce.
SUMMARY: The U.S. Department of Commerce (Commerce) determines, in the
context of this changed circumstances review (CCR) of the antidumping
duty (AD) order on glycine from the People's Republic of China (China),
that Salvi Chemical Industries Ltd. (Salvi) is ineligible to
participate in the importer certification process because Salvi failed
to demonstrate that it no longer uses Chinese-origin glycine in its
production process and failed to demonstrate that it maintains its
books and records to accurately document the origin of the in-scope
materials entering its inventory which are used to process glycine. As
a result, glycine produced, processed, or exported by Salvi continues
to be subject to the AD order on glycine from China.
DATES: Applicable March 4, 2026.
FOR FURTHER INFORMATION CONTACT: Tyler Weinhold, AD/CVD Operations,
Office VI, Enforcement and Compliance, International Trade
Administration, U.S. Department of Commerce, 1401 Constitution Avenue
NW, Washington, DC 20230; telephone: (202) 482-1121.
SUPPLEMENTARY INFORMATION:
Background
On April 1, 2025, Commerce published the Preliminary Results of
this CCR, determining that Salvi demonstrated that it eliminated the
use of Chinese inputs from its processing of glycine in fiscal years
2021-2022 and 2022-2023 and that it maintains its books and records to
accurately document the origin of the in-scope materials entering its
inventory which are used to process glycine.\1\
---------------------------------------------------------------------------
\1\ See Glycine from the People's Republic of China: Notice of
Preliminary Results of Antidumping Duty Changed Circumstances
Review, 90 FR at 14359 (April 1, 2025) (Preliminary Results).
---------------------------------------------------------------------------
Due to the lapse in appropriations and Federal Government shutdown,
on November 14, 2025, Commerce tolled all deadlines in administrative
proceedings by 47 days.\2\ Additionally, due to a backlog of documents
that were electronically filed via Enforcement and Compliance's
Antidumping and Countervailing Duty Centralized Electronic Service
System (ACCESS) during the Federal Government shutdown, on November 24,
2025, Commerce tolled all deadlines in administrative proceedings by an
additional 21 days.\3\ Between April 2025 and February 2026, Commerce
extended the deadline for these final results of review.\4\
Accordingly, the deadline for these final results is now February 27,
2026.\5\ For a complete description of the events that followed the
Preliminary Results, see the Issues and Decision Memorandum.\6\
---------------------------------------------------------------------------
\2\ See Memorandum, ``Deadlines Affected by the Shutdown of the
Federal Government,'' dated November 14, 2025.
\3\ See Memorandum, ``Tolling of all Case Deadlines,'' dated
November 24, 2025.
\4\ See Memoranda, ``Extension of Deadline for Final Results of
Changed Circumstances Review,'' dated April 11, 2025; ``Extension of
Deadline for Final Results of Changed Circumstances Review,'' dated
June 20, 2025; ``Extension of Deadline for Final Results of Changed
Circumstances Review,'' dated September 12, 2025; ``Extension of
Deadline for Final Results of Changed Circumstances Review,'' dated
November 25, 2025; and ``Extension of Deadline for Final Results of
Changed Circumstances Review,'' dated February 10, 2026.
\5\ See Memorandum, ``Extension of Deadline for Final Results of
Changed Circumstances Review,'' dated February 10, 2026.
\6\ See Memorandum, ``Issues and Decision Memorandum for the
Final Results of Changed Circumstances Review of the Antidumping
Duty Order on Glycine from the People's Republic of China; Salvi
Chemical Industries Ltd.,'' dated concurrently with, and hereby
adopted by, this notice (Issues and Decision Memorandum).
---------------------------------------------------------------------------
Scope of the Order <SUP>7</SUP>
---------------------------------------------------------------------------
\7\ See Antidumping Duty Order: Glycine from the People's
Republic of China, 60 FR 16116 (March 29, 1995) (Order).
---------------------------------------------------------------------------
The product covered by the Order is glycine, which is a free-
flowing crystalline material, like salt or sugar. For a complete
description of the scope of the Order, see the Issues and Decision
Memorandum.\8\
---------------------------------------------------------------------------
\8\ See Issues and Decision Memorandum at 3.
---------------------------------------------------------------------------
Analysis of Comments Received
All issues raised are addressed in the Issues and Decision
Memorandum,\9\ and are listed in the appendix to this notice. The
Issues and Decision Memorandum is a public document and is on file
electronically via ACCESS. ACCESS is available to registered users at
<a href="https://access.trade.gov">https://access.trade.gov</a>. In addition, a complete version of the Issues
and Decision Memorandum can be accessed directly at <a href="https://access.trade.gov/public/FRNoticesListLayout.aspx">https://access.trade.gov/public/FRNoticesListLayout.aspx</a>.
---------------------------------------------------------------------------
\9\ Id. at 4-9.
---------------------------------------------------------------------------
Final Results of Changed Circumstances Review
Commerce finds that, based upon the record of this CCR, Salvi
failed to demonstrate that it no longer uses Chinese-origin glycine and
is ineligible to participate in the importer certification process \10\
because, after further review of the record evidence and comments
submitted, we find that Salvi failed to maintain its books and records
to accurately document the origin of the in-scope China-origin glycine
entering its inventory which is used to process glycine. As a result,
glycine produced, processed, or exported by Salvi continues to be
subject to the Order on glycine from China.
---------------------------------------------------------------------------
\10\ See Glycine from the People's Republic of China: Final
Partial Affirmative Determination of Circumvention of the
Antidumping Duty Order, 77 FR 73426, 73427 (December 10, 2012).
---------------------------------------------------------------------------
Administrative Protective Order (APO)
This notice serves as a final reminder to parties subject to an APO
of their responsibility concerning the disposition of proprietary
information disclosed under APO in accordance with 19 CFR
351.305(a)(3). Timely written notification of the return or destruction
of APO materials or conversion to a judicial protective order is hereby
requested. Failure to comply with the regulations and terms of an APO
is a sanctionable violation.
Notification to Interested Parties
This notice is published in accordance with sections 751(b) and
777(i) of the Act, and 19 CFR 351.216, 19 CFR 351.221(c)(3), and 19 CFR
351.222(g).
Dated: February 27, 2026.
Christopher Abbott,
Deputy Assistant Secretary for Policy and Negotiations, performing the
non-exclusive functions and duties of the Assistant Secretary for
Enforcement and Compliance.
Appendix
List of Topics Discussed in the Issues and Decision Memorandum
I. Summary
II. Background
III. Scope of the Order
IV. Changes Since the Preliminary Results
V. Discussion of the Issues
[[Page 10589]]
Comment 1: Whether Commerce Can Conduct a Changed Circumstances
Review with Respect to Salvi
Comment 2: Whether Salvi Has Demonstrated that It No Longer Uses
Chinese Glycine Inputs and Is Able to Identify the Country of Origin
of Its Glycine Inputs
VI. Recommendation
[FR Doc. 2026-04323 Filed 3-3-26; 8:45 am]
BILLING CODE 3510-DS-P
</pre></body>
</html>Indexed from Federal Register on March 4, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.